The Scientist

» pharmaceuticals and culture

Most Recent

image: Following the Funding

Following the Funding

By | November 4, 2015

Researchers use network theory to estimate the importance of relationships among researchers and institutions in attracting grant money.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

The Psychology of Overeating, The Hidden Half of Nature, The Death of Cancer, and The Secret of Our Success

0 Comments

image: 2015 Life Sciences Salary Survey

2015 Life Sciences Salary Survey

By and | November 1, 2015

This year’s survey highlights dramatic regional, sector, and gender variations.

13 Comments

image: Daraprim Alternative

Daraprim Alternative

By | October 22, 2015

A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.

1 Comment

image: Scientists Skip Cell Line Validation

Scientists Skip Cell Line Validation

By | October 12, 2015

Despite known problems with contamination and mislabeled cell lines, most researchers continue to operate without authenticating cells’ identity.

2 Comments

image: Debating the Value of Anonymity

Debating the Value of Anonymity

By | October 5, 2015

PubPeer responds to criticism that anonymous post-publication peer review threatens the scientific process.

1 Comment

image: Teva Buys Mexican Pharma Firm

Teva Buys Mexican Pharma Firm

By | October 5, 2015

The Israeli drugmaker is purchasing the pharmaceutical company Rimsa for $2.3 billion.

0 Comments

image: Ready, Willing, and Able

Ready, Willing, and Able

By | October 1, 2015

Researchers with disabilities are making their fields more accessible.

0 Comments

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

image: Drug Pricing Incites Outrage

Drug Pricing Incites Outrage

By | September 22, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS